| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000006692 |
| Receipt No. | R000007911 |
| Official scientific title of the study | Analysis of susceptibility moleculde for idiopahtic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) |
| Date of disclosure of the study information | 2011/11/15 |
| Last modified on | 2017/11/13 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Analysis of susceptibility moleculde for idiopahtic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD) | |
| Title of the study (Brief title) | Gene expression analysis of pulmonary fibrosis and emphysema | |
| Region |
|
|
| Condition | |||
| Condition | idiopatic pulmonary fibrosis
chronic obstructive lung disease |
||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To clarify the molecules relating to the development of pulmonary fibrosis and emphysema by accomplishing comprehensive gene expression analysis of fibrotic and emphysematous lung tissue. |
| Basic objectives2 | Others |
| Basic objectives -Others | Lung tissue without lung cancer obtained by surgical resection of lung cancer will be used. Lung tissue from patients with pulmonary fibrosis, emphysema and without these changes will be afforded to comprehensive gene expression analysis. Difference in gene expression will be analyzed to find out important molecules for pulmonary fibrosis and emphysema. |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Difference in gene expression between the lung tissue from the patient with pulmonary fibrosis, emphysema and without these. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | In the case who recieved surgical resection of lung cancer, who have pumonary fibrosis or emphysema or normal lung | |||
| Key exclusion criteria | The cases with lung disases other than pumonary fibrosis and emphysema | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Mitsuru Munakata |
| Organization | Fukusima Medical University |
| Division name | Department of Pulmonary Medicine |
| Address | Hikarigaoka-1, Fukusima City |
| TEL | 024-547-1360 |
| munakata@fmu.ac.jp | |
| Public contact | |
| Name of contact person | Mitsuru Munakata |
| Organization | Fukusima Medical University |
| Division name | Department of Pulmonary Medicine |
| Address | Hikarigaoka-1, Fukusima City |
| TEL | 024-547-1360 |
| Homepage URL | |
| munakata@fmu.ac.jp | |
| Sponsor | |
| Institute | Fukusima Medical University, School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Fukushima Medical University
Japan Society for the Promotion of Science |
| Organization | |
| Division | |
| Category of Funding Organization | Local Government |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Retrospective, case-control study to eluciddate characteristically expressed molelules for pulmonary fibrosis and emphysema |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000007911 |